SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-007956
Filing Date
2020-05-07
Accepted
2020-05-07 16:27:08
Documents
82
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1317502
2 ex31-1.htm EX-31.1 11092
3 ex31-2.htm EX-31.2 17729
4 ex32-1.htm EX-32.1 9485
  Complete submission text file 0001493152-20-007956.txt   6340342

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE lctx-20200331.xml EX-101.INS 973770
6 XBRL SCHEMA FILE lctx-20200331.xsd EX-101.SCH 84008
7 XBRL CALCULATION FILE lctx-20200331_cal.xml EX-101.CAL 83038
8 XBRL DEFINITION FILE lctx-20200331_def.xml EX-101.DEF 393718
9 XBRL LABEL FILE lctx-20200331_lab.xml EX-101.LAB 522324
10 XBRL PRESENTATION FILE lctx-20200331_pre.xml EX-101.PRE 435053
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 20856888
SIC: 2836 Biological Products, (No Diagnostic Substances)